Safe Discharge Criteria After Curative Gastrectomy for Gastric Cancer

다국어 초록 (Multilingual Abstract)

Purpose This study aimed to investigate the relationship between clinical and laboratory parameters and complication status to predict which patients can be safely discharged from the hospital on the third postoperative day (POD).




Materials and Methods Data from a prospectively maintained database of 2,110 consecutive patients with gastric adenocarcinoma who underwent curative surgery were reviewed. The third POD vital signs, laboratory data, and details of the course after surgery were collected. Patients with grade II or higher complications after the third POD were considered unsuitable for early discharge. The performance metrics were calculated for all algorithm parameters. The proposed algorithm was tested using a validation dataset of consecutive patients from the same center.




Results Of 1,438 patients in the study cohort, 142 (9.9%) were considered unsuitable for early discharge. C-reactive protein level, body temperature, pulse rate, and neutrophil count had good performance metrics and were determined to be independent prognostic factors. An algorithm consisting of these 4 parameters had a negative predictive value (NPV) of 95.9% (95% confidence interval [CI], 94.2–97.3), sensitivity of 80.3% (95% CI, 72.8–86.5), and specificity of 51.1% (95% CI, 48.3–53.8). Only 28 (1.9%) patients in the study cohort were classified as false negatives. In the validation dataset, the NPV was 93.7%, sensitivity was 66%, and 3.3% (17/512) of patients were classified as false negatives.




Conclusions Simple clinical and laboratory parameters obtained on the third POD can be used when making decisions regarding the safe early discharge of patients who underwent gastrectomy.

다국어 초록 (Multilingual Abstract)

Purpose This study aimed to investigate the relationship between clinical and laboratory parameters and complication status to predict which patients can be safely discharged from the hospital on the third postoperative day (POD).


Materials and Methods Data from a prospectively maintained database of 2,110 consecutive patients with gastric adenocarcinoma who underwent curative surgery were reviewed. The third POD vital signs, laboratory data, and details of the course after surgery were collected. Patients with grade II or higher complications after the third POD were considered unsuitable for early discharge. The performance metrics were calculated for all algorithm parameters. The proposed algorithm was tested using a validation dataset of consecutive patients from the same center.


Results Of 1,438 patients in the study cohort, 142 (9.9%) were considered unsuitable for early discharge. C-reactive protein level, body temperature, pulse rate, and neutrophil count had good performance metrics and were determined to be independent prognostic factors. An algorithm consisting of these 4 parameters had a negative predictive value (NPV) of 95.9% (95% confidence interval [CI], 94.2–97.3), sensitivity of 80.3% (95% CI, 72.8–86.5), and specificity of 51.1% (95% CI, 48.3–53.8). Only 28 (1.9%) patients in the study cohort were classified as false negatives. In the validation dataset, the NPV was 93.7%, sensitivity was 66%, and 3.3% (17/512) of patients were classified as false negatives.


Conclusions Simple clinical and laboratory parameters obtained on the third POD can be used when making decisions regarding the safe early discharge of patients who underwent gastrectomy.

참고문헌 (Reference)

1 Clavien PA, "The Clavien-Dindo classification of surgical complications : five-year experience" 250 : 187-196, 2009

2 Korevaar DA, "Targeted test evaluation : a framework for designing diagnostic accuracy studies with clear study hypotheses" 3 : 22-, 2019

3 Viyuela García C, "Systemic inflammatory markers for the detection of infectious complications and safe discharge after cytoreductive surgery and HIPEC" 34 : 163-167, 2020

4 Tian Y, "Randomized controlled trial comparing the short-term outcomes of enhanced recovery after surgery and conventional care in laparoscopic distal gastrectomy(GISSG1901)" 275 : e15-e21, 2022

5 Guner A, "Prognostic value of postoperative neutrophil and albumin : reassessment one month after gastric cancer surgery" 11 : 633924-, 2021

6 Yang W, "Procalcitonin as an early predictor of intra-abdominal infections following gastric cancer resection" 258 : 352-361, 2021

7 van Winsen M, "Postoperative C-reactive protein concentrations to predict infective complications following gastrectomy for cancer" 124 : 1060-1069, 2021

8 Dutta S, "Persistent elevation of C-reactive protein following esophagogastric cancer resection as a predictor of postoperative surgical site infectious complications" 35 : 1017-1025, 2011

9 Guner A, "Parameters for predicting surgical outcomes for gastric cancer patients : simple is better than complex" 25 : 3239-3247, 2018

10 Zhao J, "Outcome of discharge within 72 hours of robotic gastrectomy using enhanced recovery after surgery programs" 28 : 1279-1286, 2018

11 Shannon AB, "Ninety-day mortality after total gastrectomy for gastric cancer" 170 : 603-609, 2021

12 Guideline Committee of the Korean Gastric Cancer Association ; Development Working Group & Review Panel, "Korean Practice Guideline for Gastric Cancer 2018; Evidence-based, Multi-disciplinary Approach" 대한위암학회 19 (19): 1-48, 2019

13 Korean Gastric Cancer Association, "Korean Gastric Cancer Association-Led Nationwide Survey on Surgically Treated Gastric Cancers in 2019" 대한위암학회 21 (21): 221-235, 2021

14 Japanese Gastric Cancer Association, "Japanese gastric cancer treatment guidelines 2018(5th edition)" 24 : 1-21, 2021

15 Park JH, "Identification of candidates for early discharge after gastrectomy" 24 : 159-166, 2017

16 Park Sin Hye ; Kang Mee Joo ; Yun E Hwa ; Jung Kyu-Won, "Epidemiology of Gastric Cancer in Korea: Trends in Incidence and Survival Based on Korea Central Cancer Registry Data (1999–2019)" 대한위암학회 22 (22): 160-168, 2022

17 Weindelmayer J, "Enhanced recovery after surgery can improve patient outcomes and reduce hospital cost of gastrectomy for cancer in the west : a propensity-score-based analysis" 28 : 7087-7094, 2021

18 Kørner H, "Diagnostic accuracy of C-reactive protein for intraabdominal infections after colorectal resections" 13 : 1599-1606, 2009

19 Yu D, "Development and external validation of safe discharge criteria after radical gastrectomy" 13 : 5251-5261, 2021

20 Roh CK, "Comparison of surgical outcomes between integrated robotic and conventional laparoscopic surgery for distal gastrectomy : a propensity score matching analysis" 10 : 485-, 2020

21 Lee YM, "Clinicopathological risk factors and biochemical predictors of safe discharge after total thyroidectomy and central compartment node dissection for thyroid cancer : a prospective study" 2015 : 214525-, 2015

22 Roh CK, "Clinical pathway for enhanced recovery after surgery for gastric cancer : a prospective single-center phase II clinical trial for safety and efficacy" 121 : 662-669, 2020

23 Yeung DE, "C-reactive protein can predict anastomotic leak in colorectal surgery : a systematic review and meta-analysis" 36 : 1147-1162, 2021

24 Welsch T, "C-reactive protein as early predictor for infectious postoperative complications in rectal surgery" 22 : 1499-1507, 2007

25 김형일 ; Ali Guner, "Biomarkers for Evaluating the Inflammation Status in Patients with Cancer" 대한위암학회 19 (19): 254-277, 2019

26 Seymour CW, "Assessment of clinical criteria for sepsis : for the third international consensus definitions for sepsis and septic shock(sepsis-3)" 315 : 762-774, 2016

27 Tavernier C, "Assessing criteria for a safe early discharge after laparoscopic colorectal surgery" 157 : 52-58, 2022

28 Amin MB, "AJCC Cancer Staging Manual" Springer International Publishing; 2017